Mr. Kibble is an experienced financial services executive across asset management and investment banking (M & A, capital markets), emerging market equities and derivatives. Matthew began his career as an accountant at Ernst and Young and spent 5 years with JPMorgan Chase in the Consumer, Healthcare and Retail Investment Banking and Institutional Asian Equities and Derivatives before launching the Latin American investment vehicle Everlight Capital. He later joined the family office private investment vehicle Cap-Meridian Ventures as a partner with a broad mandate to invest in numerous asset classes globally, mainly disruptive technologies with superior operations teams. Early stage portfolio companies included: Casper, Compass, Credible, Modern Meadow, Palantir and Peloton.
With a similar thesis but now more opportunistic (including more consumer companies) Matthew originates, structures and invests through Australy International and Kibble Holdings. The portfolio includes Andina Acquisition Corporation II and III (SPACs), Dogiz, Dr Sniff, Kibble Pet, Kibble Pet Groom (Pet vertical), Eaton Hemp, Ilegal Mezcal, Out East Rosé (Consumer focus), Amigo Technologies, Conexus AI, Kaptyn Transportation, Mode Maison, Nantero, Sargon Capital, Triax Technologies, YouPlus and Zefun (Tech focus).
Matthew is a director of Andina Acquisition Corporation III, Eaton Hemp, Kaptyn, Kibble Pet and Sargon Capital. He holds a Bachelor of Commerce degree, majoring in Finance and Accounting, and a Bachelor of Science degree, majoring in Biomedical Sciences, both from the University of Queensland, Australia